Obesity Clinical Trial
Official title:
Linking Temporal Patterns of Modifiable Behaviors to Weight Loss Outcomes
Verified date | May 2024 |
Source | University of Colorado, Denver |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
This study is designed as an observational trial. The objective of this study is to follow-up with participants 3 years after completion of an 18-month comprehensive behavioral weight loss intervention. Outcomes of interest include change in body weight, body composition, physical activity, energy intake, and sleep. In addition, investigators will explore the associations between current physical activity, sleep, and energy intake patterns and body weight regulation.
Status | Enrolling by invitation |
Enrollment | 60 |
Est. completion date | January 2025 |
Est. primary completion date | January 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: - Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356) - Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial) - Capable and willing to give informed consent - Possess a smartphone to install and utilize the meal timing application - Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days - Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria: - Being considered unsafe to participate as determined by the study physician (Dr. Catennaci) - New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases) - Women who became pregnant after completing the Parent Trial - Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep |
Country | Name | City | State |
---|---|---|---|
United States | University of Colorado Anschutz Medical Campus | Aurora | Colorado |
Lead Sponsor | Collaborator |
---|---|
University of Colorado, Denver | National Heart, Lung, and Blood Institute (NHLBI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Weight Change | Change in body weight (kg) | Baseline to 54 months | |
Primary | Weight Maintenance | Change in body weight (kg) | 18 months to 54 months | |
Primary | Fat Mass Change | Change in Fat Mass (kg) | Baseline to 54 months | |
Primary | Fat Free Mass Change | Change in Fat Free Mass (kg) | Baseline to 54 months | |
Primary | Fat Mass Maintenance | Change in Fat Mass (kg) | 18 months to 54 months | |
Primary | Fat Free Mass Maintenance | Change in Fat Free Mass (kg) | 18 months to 54 months | |
Secondary | Change in Physical Activity Patterns | Physical activity patterns as measured by SenseWear armband (min/day) | 0, 6, 12, 18, 24, 54 month | |
Secondary | Physical Activity Patterns | Physical activity patterns as measured by ActivPAL, Actigraph (min/day) | 54 month | |
Secondary | Change in Sleep | Sleep patterns as measured by SenseWear armband (h/day) | 0, 6, 12, 18, 24, 54 month | |
Secondary | Sleep Patterns | Sleep patterns as measured by Actiwatch-2, ActivPAL, Actigraph (h/day) | 54 month | |
Secondary | Change in Energy Intake | Energy Intake patterns as measured by 3 day food record (kcal/day | 0, 6, 12, 18, 54 month | |
Secondary | Energy Intake Patterns | Energy Intake patterns as measured by 24 hour food recall and meallogger smartphone application (kcal/day) | 54 month | |
Secondary | Resting Metabolic Rate | Resting metabolic rate as measured using indirect calorimetry (kcal/day) | 54 month | |
Secondary | Total Daily Energy Expenditure | Total Daily Energy Expenditure as measured by doubly labeled water (kcal/day) | 54 month | |
Secondary | Physical Activity Energy Expenditure | Physical Activity Energy Expenditure as measured by doubly labeled water (kcal/day) | 54 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |